Loading…
Association of Bowman’s capsule rupture with prognosis in patients with lupus nephritis
Background and objective Lupus nephritis is one of the most severe manifestations of systemic lupus erythematosus. The clinical and prognostic significance of Bowman’s capsule rupture in patients with lupus nephritis is unknown. Methods One hundred eighty patients with lupus nephritis were enrolled...
Saved in:
Published in: | Journal of nephrology 2022-05, Vol.35 (4), p.1193-1204 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background and objective
Lupus nephritis is one of the most severe manifestations of systemic lupus erythematosus. The clinical and prognostic significance of Bowman’s capsule rupture in patients with lupus nephritis is unknown.
Methods
One hundred eighty patients with lupus nephritis were enrolled in the study and the integrity of Bowman’s capsule was assessed. Both inflammatory and proliferative cells were detected by immunochemistry staining. The primary events of interest were end-stage renal disease and death.
Results
After retrospective analysis of the data, 52 (28.9%) patients were found to have Bowman’s capsule rupture, which was accompanied by high levels of serum creatinine, 24 h urine protein, and Activity/Chronicity Index. Bowman’s capsule rupture was correlated with the level of crescents, tubular atrophy, and interstitial fibrosis. The number of CD20
+
cells was higher in the Bowman’s capsule rupture ( +) group compared with the Bowman’s capsule rupture (−) group, while no differences in other inflammatory cells were observed. In addition, the end stage renal disease-free survival in the Bowman’s capsule rupture ( +) group was lower than in the Bowman’s capsule rupture (−) group. Moreover, serum creatinine (HR 39.56,
P
|
---|---|
ISSN: | 1724-6059 1724-6059 |
DOI: | 10.1007/s40620-022-01316-x |